| Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study C Bezzio, S Saibeni, A Variola, M Allocca, A Massari, V Gerardi, V Casini, ... Gut 69 (7), 1213-1217, 2020 | 345 | 2020 |
| Intestinal epithelial cells in inflammatory bowel diseases G Roda, A Sartini, E Zambon, A Calafiore, M Marocchi, A Caponi, ... World journal of gastroenterology: WJG 16 (34), 4264, 2010 | 198 | 2010 |
| Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study J Burisch, H Vardi, D Schwartz, M Friger, G Kiudelis, J Kupčinskas, ... The lancet Gastroenterology & hepatology 5 (5), 454-464, 2020 | 100 | 2020 |
| Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease A Sartini, S Gitto, M Bianchini, MC Verga, M Di Girolamo, A Bertani, ... Cell death & disease 9 (2), 87, 2018 | 88 | 2018 |
| Cytokine networks in ulcerative colitis G Roda, M Marocchi, A Sartini, E Roda Ulcers 2011, 1-5, 2011 | 69 | 2011 |
| Eicosapentaenoic acid reduces fecal levels of calprotectin and prevents relapse in patients with ulcerative colitis E Scaioli, A Sartini, M Bellanova, M Campieri, D Festi, F Bazzoli, ... Clinical Gastroenterology and Hepatology 16 (8), 1268-1275. e2, 2018 | 58 | 2018 |
| Curcuma longa Extract Exerts a Myorelaxant Effect on the Ileum and Colon in a Mouse Experimental Colitis Model, Independent of the Anti-Inflammatory Effect R Aldini, R Budriesi, G Roda, M Micucci, P Ioan, A D’Errico-Grigioni, ... Public Library of Science 7 (9), e44650, 2012 | 49 | 2012 |
| Low molecular weight heparin does not increase bleeding and mortality post‐endoscopic variceal band ligation in cirrhotic patients M Bianchini, G Cavani, A Bonaccorso, L Turco, F Vizzutti, A Sartini, S Gitto, ... Liver international 38 (7), 1253-1262, 2018 | 48 | 2018 |
| Fecal Detection of Mycobacterium avium Paratuberculosis Using the IS900 DNA Sequence in Crohn’s Disease and Ulcerative Colitis Patients and Healthy Subjects A Tuci, F Tonon, L Castellani, A Sartini, G Roda, M Marocchi, A Caponi, ... Digestive diseases and sciences 56, 2957-2962, 2011 | 46 | 2011 |
| Real-life effectiveness of ustekinumab in inflammatory bowel disease patients with concomitant psoriasis or psoriatic arthritis: An IG-IBD study D Pugliese, M Daperno, G Fiorino, E Savarino, E Mosso, L Biancone, ... Digestive and Liver Disease 51 (7), 972-977, 2019 | 37 | 2019 |
| Epi-IBD group J Burisch, H Vardi, D Schwartz, M Friger, G Kiudelis, J Kupčinskas, ... Health-care costs of inflammatory bowel disease in a pan-European, community …, 2018 | 27 | 2018 |
| Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG‐IBD LIVE study D Pugliese, G Privitera, F Crispino, N Mezzina, F Castiglione, G Fiorino, ... Alimentary pharmacology & therapeutics 56 (1), 95-109, 2022 | 26 | 2022 |
| Sulfasalazine in prevention of pouchitis after proctocolectomy with ileal pouch–anal anastomosis for ulcerative colitis E Scaioli, A Sartini, E Liverani, RJ Digby, G Ugolini, G Rosati, G Poggioli, ... Digestive diseases and sciences 62, 1016-1024, 2017 | 25 | 2017 |
| The use of 5-aminosalicylate for patients with Crohn’s disease in a prospective European inception cohort with 5 years follow-up–an Epi-IBD study J Burisch, D Bergemalm, J Halfvarson, V Domislovic, Z Krznaric, A Goldis, ... United European gastroenterology journal 8 (8), 949-960, 2020 | 23 | 2020 |
| Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care S Saibeni, L Scucchi, G Dragoni, C Bezzio, A Miranda, DG Ribaldone, ... United European Gastroenterology Journal 8 (10), 1228-1235, 2020 | 16 | 2020 |
| The other side of malnutrition in inflammatory bowel disease (IBD): non-alcoholic fatty liver disease G Gibiino, A Sartini, S Gitto, C Binda, M Sbrancia, C Coluccio, V Sambri, ... Nutrients 13 (8), 2772, 2021 | 13 | 2021 |
| Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS‐CoV‐2 infection: an IG‐IBD study C Bezzio, A Armuzzi, F Furfaro, S Ardizzone, M Milla, S Carparelli, ... Alimentary Pharmacology & Therapeutics 54 (11-12), 1432-1441, 2021 | 11 | 2021 |
| The use of obeticholic acid for the management of non-viral liver disease: current clinical practice and future perspectives S Gitto, V Guarneri, A Sartini, P Andreone Expert Review of Gastroenterology & Hepatology 12 (2), 165-171, 2018 | 11 | 2018 |
| Update on Crohn's disease: a polymorphic entity. A Sartini, L Castellani, F Buonfiglioli, G Roda, A Belluzzi, E Roda Minerva gastroenterologica e dietologica 57 (1), 89-96, 2011 | 11 | 2011 |
| Antimicrobial stewardship in a Gastroenterology Department: Impact on antimicrobial consumption, antimicrobial resistance and clinical outcome A Bedini, N De Maria, M Del Buono, M Bianchini, M Mancini, C Binda, ... Digestive and Liver Disease 48 (10), 1142-1147, 2016 | 9 | 2016 |
Erica VillaUniversity of Modena and Reggio EmiliaEmail verificata su unimore.it
